Enhancing Transatlantic Ties in Life Sciences and Addressing Women's Health Investment Gaps

Strengthening Transatlantic Ties in Life Sciences Innovation

On January 19, 2026, a significant gathering of over 200 leaders from Italy and the United States convenes in San Francisco for the ninth edition of "Italy on the Move." This event seeks to enhance transatlantic dialogue regarding life sciences innovation and investment, showcasing the growing prominence of Italian biotech firms on the global stage. Organized by the Italian Trade Agency in collaboration with various Italian governmental bodies and industry associations, the event coincides with the J.P. Morgan Annual Healthcare Conference, emphasizing strategic partnerships between Italy and the U.S. in the life sciences sector.

The agenda features key remarks from influential figures, including Massimo Carnelos, Consul General of Italy in San Francisco, and Sergio Strozzi, Head of Innovation, Technology, and Startups at the Ministry of Foreign Affairs and International Cooperation. Notably, the event provides a comprehensive overview of Italy's life sciences ecosystem, highlighting public support initiatives aimed at fostering innovation. A video message from Augusto Reggiani, Director of the Office for Foreign Direct Investment (FDI) Attraction, further underscores Italy's commitment to attracting investment and collaboration from American counterparts.

A highlight of the event is the roundtable titled "Invest in Innovation: The Italian Life Science Momentum," moderated by David Whelan of Bespoke Strategy. Industry leaders, including Lucia Faccio, CEO of Genespire, and Bryan Giraudo, CFO & COO of Gossamer Bio, participate in discussions that illuminate the burgeoning opportunities within Italy’s biotech landscape. This initiative not only reflects Italy’s dedication to strengthening its position in the life sciences sector but also emphasizes the importance of collaboration with U.S. companies to drive innovation and investment in healthcare solutions.

Emerging Opportunities in Women's Health Investment

In a related development, the World Economic Forum's 2026 Women's Health Investment Outlook sheds light on the alarming underfunding of women's health issues. Despite women representing nearly half of the global population, only 6% of private healthcare investment is allocated to their health needs. The report emphasizes the necessity for a strategic shift in investment priorities, particularly in addressing high-burden conditions such as cardiovascular disease and Alzheimer's that disproportionately affect women.

This underinvestment not only threatens women's well-being but also presents a significant economic opportunity that remains untapped. Stakeholders are urged to recognize disparities within the healthcare system and prioritize broader investment strategies to enhance overall health outcomes for women, thereby contributing to improved workforce participation and economic growth.